Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars

This randomized active-controlled clinical trial using a split-face design compares the efficacy and tolerability of the at-home application of topical tazarotene gel, 0.1%, and physician-administered microneedle therapy for the treatment of facial atrophic postacne scarring.
Source: JAMA Facial Plastic Surgery - Category: Cosmetic Surgery Source Type: research